Jun 11 |
Sidoti Events, LLC's Virtual June Small-Cap Conference
|
Jun 6 |
Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
|
Jun 5 |
Atossa to Present at the Sidoti Small-Cap Investor Conference
|
May 28 |
Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model
|
May 20 |
Atossa Genetics Inc. (ATOS) is a Great Momentum Stock: Should You Buy?
|
May 15 |
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
|
May 13 |
Atossa Therapeutics files for $100M mixed shelf offering
|
May 13 |
Atossa Therapeutics GAAP EPS of -$0.05
|
May 13 |
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
|
May 7 |
Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
|